Siegel PM - Search Results

1

Chordin-Like 1 Suppresses Bone Morphogenetic Protein 4-Induced Breast Cancer Cell Migration and Invasion.

Cyr-Depauw C, Northey JJ, Tabariès S, Annis MG, Dong Z, Cory S, Hallett M, Rennhack JP, Andrechek ER, Siegel PM. Cyr-Depauw C, et al. Among authors: siegel pm. Mol Cell Biol. 2016 May 2;36(10):1509-25. doi: 10.1128/MCB.00600-15. Print 2016 May 15. Mol Cell Biol. 2016. PMID: 26976638 Free PMC article.

2

Accelerated mammary tumor development in mutant polyomavirus middle T transgenic mice expressing elevated levels of either the Shc or Grb2 adapter protein.

Rauh MJ, Blackmore V, Andrechek ER, Tortorice CG, Daly R, Lai VK, Pawson T, Cardiff RD, Siegel PM, Muller WJ. Rauh MJ, et al. Among authors: siegel pm. Mol Cell Biol. 1999 Dec;19(12):8169-79. doi: 10.1128/MCB.19.12.8169. Mol Cell Biol. 1999. PMID: 10567542 Free PMC article.

3

Amplification of the neu/erbB-2 oncogene in a mouse model of mammary tumorigenesis.

Andrechek ER, Hardy WR, Siegel PM, Rudnicki MA, Cardiff RD, Muller WJ. Andrechek ER, et al. Among authors: siegel pm. Proc Natl Acad Sci U S A. 2000 Mar 28;97(7):3444-9. doi: 10.1073/pnas.97.7.3444. Proc Natl Acad Sci U S A. 2000. PMID: 10716706 Free PMC article.

4

Gene expression profiling of neu-induced mammary tumors from transgenic mice reveals genetic and morphological similarities to ErbB2-expressing human breast cancers.

Andrechek ER, Laing MA, Girgis-Gabardo AA, Siegel PM, Cardiff RD, Muller WJ. Andrechek ER, et al. Among authors: siegel pm. Cancer Res. 2003 Aug 15;63(16):4920-6. Cancer Res. 2003. PMID: 12941816

5

Targeting aberrant TGF-beta signaling in pre-clinical models of cancer.

Mourskaia AA, Northey JJ, Siegel PM. Mourskaia AA, et al. Among authors: siegel pm. Anticancer Agents Med Chem. 2007 Sep;7(5):504-14. doi: 10.2174/187152007781668689. Anticancer Agents Med Chem. 2007. PMID: 17896911 Review.

6

Osteoactivin promotes breast cancer metastasis to bone.

Rose AA, Pepin F, Russo C, Abou Khalil JE, Hallett M, Siegel PM. Rose AA, et al. Among authors: siegel pm. Mol Cancer Res. 2007 Oct;5(10):1001-14. doi: 10.1158/1541-7786.MCR-07-0119. Mol Cancer Res. 2007. PMID: 17951401

7

Signaling through ShcA is required for transforming growth factor beta- and Neu/ErbB-2-induced breast cancer cell motility and invasion.

Northey JJ, Chmielecki J, Ngan E, Russo C, Annis MG, Muller WJ, Siegel PM. Northey JJ, et al. Among authors: siegel pm. Mol Cell Biol. 2008 May;28(10):3162-76. doi: 10.1128/MCB.01734-07. Epub 2008 Mar 10. Mol Cell Biol. 2008. PMID: 18332126 Free PMC article.

8

Transforming growth factor-beta1 is the predominant isoform required for breast cancer cell outgrowth in bone.

Mourskaia AA, Dong Z, Ng S, Banville M, Zwaagstra JC, O'Connor-McCourt MD, Siegel PM. Mourskaia AA, et al. Among authors: siegel pm. Oncogene. 2009 Feb 19;28(7):1005-15. doi: 10.1038/onc.2008.454. Epub 2008 Dec 15. Oncogene. 2009. PMID: 19079339

9

GATA3 inhibits breast cancer growth and pulmonary breast cancer metastasis.

Dydensborg AB, Rose AA, Wilson BJ, Grote D, Paquet M, Giguère V, Siegel PM, Bouchard M. Dydensborg AB, et al. Among authors: siegel pm. Oncogene. 2009 Jul 23;28(29):2634-42. doi: 10.1038/onc.2009.126. Epub 2009 Jun 1. Oncogene. 2009. PMID: 19483726

10

The Ste20-like kinase SLK is required for ErbB2-driven breast cancer cell motility.

Roovers K, Wagner S, Storbeck CJ, O'Reilly P, Lo V, Northey JJ, Chmielecki J, Muller WJ, Siegel PM, Sabourin LA. Roovers K, et al. Among authors: siegel pm. Oncogene. 2009 Aug 6;28(31):2839-48. doi: 10.1038/onc.2009.146. Epub 2009 Jun 15. Oncogene. 2009. PMID: 19525980

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

171 results

Search Page

Filters